Cabergoline Effect on Blood Sugar in Type 2 Diabetics

Mashhad University of Medical Sciences

Status: Unknown

Conditions: Diabetes Type 2

Treatments: Drug: Cabergoline

Study type: Interventional

Funder types: Other

Identifiers

NCT01459601

CabergolinDM

Details and patient eligibility

About

Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.

Enrollment: 10 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 diabetes
• HbA1C>7

Exclusion criteria

• HbA1C>10
• Psychiatric disorders

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Single Blind